Why the study?
Acute non-variceal upper gastrointestinal bleeding can cause hypovolemia, hypotension, and shock, leading to elevated cardiac troponin levels, but the clinical significance of elevated cTnI in these patients remains to be evaluated.
Does elevated cardiac troponin I affect survival in patients with acute non-variceal upper gastrointestinal bleeding?
Does elevated cardiac troponin I affect survival in patients with acute non-variceal upper gastrointestinal bleeding?
The study aims to evaluate the clinical significance and effect on survival of elevated cardiac troponin I in patients with acute non-variceal upper gastrointestinal bleeding.
Elevated cTnI predicts poorer survival in ANVUGIB; leaves open whether it improves risk stratification beyond Rockall score.
Introduction: Acute non-variceal upper gastrointestinal bleeding (ANVUGIB) is an important public health problem with high rates of morbidity and mortality. ANVUGIB results in hypovolemia, hypotension, and shock, increasing cardiac oxygen use and may cause elevated serum levels of cardiac troponin (cTn). In this study, we aimed to evaluate whether elevated cTnI has clinical significance in patients with ANVUGIB.
No takes yet. Share an insight, caveat, or question.
Dertli et al. (2021) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: